Since APN can increase insulin sensitivity in the body, it is reasonable to believe that the complex synergistic interaction between APN and the IGF system or other various obesity-related biomarkers can induce tumorigenesis and development. The gene discussed is ANPEP; the disease is obesity due to melanocortin 4 receptor deficiency.